Dysbetalipoproteinemia

• CLINICAL_TRIALS approval · 2025-10-28
  Clinical Trial Update: Compassionate Use of Evinacumab

  Evinacumab (brand Evkeeza) has gained marketing approval for use in pediatric homozygous familial hypercholesterolemia, as well as indicatio…

• FDA approval · 2023-03-24
  FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for fenofibrate submitted by Mylan Pharmaceuticals Inc., for a generic fenofibrate product.